Stock & Company Details
Creative Medical Technology Holdings Inc $CELZ
Price:
46,691,331
3.7M
$5.4M
52 Week High:
$66.15
10 Day Average Volume:
42,760,466
0.00
50 Day Moving Average:
$156.49
52 Week Low:
$43.74
30 Day Average Volume:
49,506,373
$4.94
2021-02-05
0.95
30 Day Change:
13%
3 Month Change:
-0.32%
Miscellaneous
CELZ technical indicators
Latest Creative Medical Technology Holdings Inc (CELZ) technical indicators as of 2026-06-30: RSI, MACD, moving averages (SMA & EMA), Bollinger Bands, Stochastic, ADX, ATR, CCI, OBV and ROC.
RSI 14:
38.67 134.1%
MACD:
-0.21 5.8%
SMA 50:
$2.15 0.9%
SMA 200:
$2.44 0.4%
EMA 20:
$1.89 2.4%
Bollinger Bands:
2.75 / 1.23
Stochastic:
8.16 12.7%
ADX 14:
24.25 7.2%
ATR 14:
0.50 113.1%
CCI 20:
143.09 139.2%
OBV:
223.85M 511.5%
ROC 12:
-31.92% 48.2%
Select a strategy to see its performance
Backtested on this stock over recent history.
| Strategy | Trend | Return | Win rate |
|---|---|---|---|
| MACD Momentum Momentum Buy when MACD turns positive (crosses above zero) and RSI confirms momentum above 50; sell when MACD falls back below zero. | – | – | |
| RSI Reversal Mean reversion Buy when RSI falls below 30 (oversold), sell when it climbs above 70 (overbought). | – | – | |
| Volatility Breakout Volatility Buy when price closes above the upper Bollinger Band, sell on reversion to the 20-day average. | – | – | |
| Strong-Trend Pullback Trend + timing In strongly trending stocks (ADX above 25), buy short-term dips (Stochastic below 30) and sell into overbought (above 80). | – | – |
Overview
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid-derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
Finance Bot
Ask your questions
Start by typing a question below.